StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Elite Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2016 it was $342.94K, up 29.3% from the year before. The highest annual figure on record is $342.94K in fiscal 2016.

Annual total debt

PeriodPeriod endValueChange
FY2016Mar 31, 2016$342.94K+29.3%
FY2015Mar 31, 2015$265.17K+149.1%
FY2014Mar 31, 2014$106.44K–
FY2013Mar 31, 2013$0–
FY2012Mar 31, 2012$0-100.0%
FY2011Mar 31, 2011$75.46K–

More Elite Pharmaceuticals figures

See a number that looks wrong?